Relación del metabolismo de la fenilalanina con el retraso mental. Estudio a realizar en el Hospital León Becerra de Milagro período 2015-2016
No hay miniatura disponible
Fecha
2016
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil. Facultad de Ciencias Médicas. Escuela de Medicina
Resumen
El presente trabajo es una investigación para determinar la relación del metabolismo de la fenilalanina con el retraso mental en pacientes atendidos en el Hospital León Becerra de Milagro.
Se realizó un estudio no experimental de tipo observacional, investigativo, descriptivo correlacional se revisaron 27 historias clínicas que correspondió a la muestra de estudio.
Concluyo diciendo que se observó que el 56% son mujeres y un 44% hombres, el grupo etario donde más se presenta el retraso mental es de 0-12 meses con el 33%. La fenilcetonuria se asocia al retraso mental en 11.1 % (3 pacientes) y con mayor frecuencia su causa es desconocida en un 33.3%
De los pacientes diagnostico con fenilcetonuria 2 son mujeres y 1 hombre.
Estos hallazgos muestran la relación de los trastornos de la fenilalanina con el retraso mental, los cuales pueden servir como marcador a tener presente y detectar la enfermedad en sus primeros estadios y evitar su progresión hacia las formas graves.
His work is an investigation to determine the ratio of phenylalanine metabolism with mental retardation in patients treated at the Miracle León Becerra Hospital. A non-experimental observational study, research, descriptive correlational 27 medical records that corresponded to the study sample was conducted to review. Conclude by saying that it was observed that 56% are women and 44% men, the age group where most mental retardation occurs is 0-12 months with 33%. Phenylketonuria is associated with mental retardation in 11.1% (3 patients) and most often the cause is unknown in 33.3% Diagnosis of patients with phenylketonuria two is women and 1 man. These findings show the relationship of disorders with mental retardation phenylalanine, which may serve as a marker to be present and to detect the disease in its early stages and prevent progression to severe forms.
His work is an investigation to determine the ratio of phenylalanine metabolism with mental retardation in patients treated at the Miracle León Becerra Hospital. A non-experimental observational study, research, descriptive correlational 27 medical records that corresponded to the study sample was conducted to review. Conclude by saying that it was observed that 56% are women and 44% men, the age group where most mental retardation occurs is 0-12 months with 33%. Phenylketonuria is associated with mental retardation in 11.1% (3 patients) and most often the cause is unknown in 33.3% Diagnosis of patients with phenylketonuria two is women and 1 man. These findings show the relationship of disorders with mental retardation phenylalanine, which may serve as a marker to be present and to detect the disease in its early stages and prevent progression to severe forms.
Descripción
Palabras clave
Retraso mental, Fenilalanina, Metabolismo, Hospital General Dr. León Becerra Camacho, Cantón Milagro, Ecuador